PT - JOURNAL ARTICLE AU - John M. Stern AU - Alexander S. Korb AU - Norman M. Spivak AU - Sergio Becerra AU - David Kronemyer AU - Négar Khanlou AU - Samuel D. Reyes AU - Martin M. Monti AU - Caroline Schnakers AU - Patricia Walshaw AU - Taylor P. Kuhn AU - Mark S. Cohen AU - William Yong AU - Itzhak Fried AU - Sheldon E. Jordan AU - Jerome Engel, Jr. AU - Mark E. Schafer AU - Alexander Bystritsky TI - Safety of Focused Ultrasound Neuromodulation in Humans with Temporal Lobe Epilepsy AID - 10.1101/2020.04.10.20060855 DP - 2020 Jan 01 TA - medRxiv PG - 2020.04.10.20060855 4099 - http://medrxiv.org/content/early/2020/04/15/2020.04.10.20060855.short 4100 - http://medrxiv.org/content/early/2020/04/15/2020.04.10.20060855.full AB - Objective Low-Intensity Focused Ultrasound Pulsations (LIFUP) is a promising new potential neuromodulation tool. However, the safety of LIFUP neuromodulation has not yet been adequately assessed. Patients with refractory temporal lobe epilepsy electing to undergo an anterior temporal lobe resection present a unique opportunity to evaluate the safety and efficacy of LIFUP neuromodulation. Because the brain tissue in these patients will be removed, histological changes in tissue after LIFUP can be examined. Evidence of effective neuromodulation was assessed using functional MRI and EEG, while further potential safety concerns were assessed using neuropsychological testing.Methods EEG, functional MRI, and neuropsychology were assessed in six patients before and after focused ultrasound sonication of the temporal lobe at intensities up to 5760 mW/cm2. Using the BrainSonix Pulsar 1002, LIFUP was delivered under MR guidance, using the Siemens Magnetom 3T Prisma scanner. Neuropsychological changes were assessed using various batteries. EEG was recorded using the Electrical Geodesics EGI 256 channel system. Histological changes were assessed using hematoxylin and eosin staining, among others.Results LIFUP was not able to modulate the BOLD signal on fMRI in a reliable and consistent manner. The EEG data that was available did not demonstrate a change in activity after LIFUP in all but one subject. Likewise, the neuropsychology testing did not show any statistically significant changes in any test, except for a slight decrease in performance on the one test after LIFUP. Lastly, the histology did not reveal any detectable damage to the tissue, except for one subject for whom the histology findings were inconclusive.Significance The safety in the histology was the primary endpoint, and as such, longer exposure at the highest intensity levels will be administered moving forward.Key PointsLIFUP is a novel brain stimulation technique with not yet fully established safety guidelines.LIFUP was administered to patients electing to undergo resective brain surgery.LIFUP does not appear to cause damage to tissue.Longer exposure times are needed to further show safety at these intensity levels.Competing Interest StatementDr. Korb is Vice-President of BrainSonix Corp and owns shares in the company. Dr. Bystritsky is the Founder and CEO of BrainSonix Corp. Other authors report no conflicts of interest. Clinical TrialNCT02151175Funding StatementThis study received funding from the BrainSonix Corporation and the Friedman Foundation. Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data that supports the findings of this study are available from the corresponding author, upon reasonable request. The requesting PI will need an MTA.